Investor Update
Basel, 10 July 2006
Invitation to conference call on Roche C.E.R.A. data and results at the European Dialysis and Transplant Association (ERA-EDTA) 2006
Monday, July 17, 2006
We kindly invite you to participate in an analyst and investor conference call to present and discuss new data and results on Roche’s C.E.R.A. that will be presented during the 2006 ERA-EDTA conference on July 15-18, Glasgow, UK.
The conference call will take place:
Monday, July 17, 2006 from 08:30 to 09:30 CET (Central European Time) / 07:30 to 08:30 BST (British Summer Time) / 02:30 to 03:30 EDT (Eastern Daylight Time)
Speakers will be:
Dr. Karl Mahler
Head of Investor Relations, Roche
Dr. Nathan Levin
Medical & Research Director of the Renal Research Institute, New York
Dr. Chris Dougherty
Clinical Science Leader, Roche
Mr. Daniel Kemmler
Commercial Director Anaemia Franchise, Roche
Analysts and investors are invited to dial in to the conference call using the following dial-in numbers:
+41 (0) 91 610 56 00 (Europe and ROW)
+44 (0) 207 107 06 11 (UK )
+1 (1) 866 291 41 66 (USA Toll Free)
Please dial in to the conference call 10 – 15 minutes before the call is scheduled to start.
Alternatively, a live audio webcast can be accessed via ir.roche.com.
Ahead of the call, the presentation will be available from the IR website at ir.roche.com.
A replay of the conference call as well as the presentation slides will be available on request after the conference call. Please contact Claudia Nyffenegger or Gaby Strausak at +41 61 688 20 03.
Invitation to conference call on Roche C.E.R.A. data and results at the European Dialysis and Transplant Association (ERA-EDTA) 2006
Monday, July 17, 2006
We kindly invite you to participate in an analyst and investor conference call to present and discuss new data and results on Roche’s C.E.R.A. that will be presented during the 2006 ERA-EDTA conference on July 15-18, Glasgow, UK.
The conference call will take place:
Monday, July 17, 2006 from 08:30 to 09:30 CET (Central European Time) / 07:30 to 08:30 BST (British Summer Time) / 02:30 to 03:30 EDT (Eastern Daylight Time)
Speakers will be:
Dr. Karl Mahler
Head of Investor Relations, Roche
Dr. Nathan Levin
Medical & Research Director of the Renal Research Institute, New York
Dr. Chris Dougherty
Clinical Science Leader, Roche
Mr. Daniel Kemmler
Commercial Director Anaemia Franchise, Roche
Analysts and investors are invited to dial in to the conference call using the following dial-in numbers:
+41 (0) 91 610 56 00 (Europe and ROW)
+44 (0) 207 107 06 11 (UK )
+1 (1) 866 291 41 66 (USA Toll Free)
Please dial in to the conference call 10 – 15 minutes before the call is scheduled to start.
Alternatively, a live audio webcast can be accessed via ir.roche.com.
Ahead of the call, the presentation will be available from the IR website at ir.roche.com.
A replay of the conference call as well as the presentation slides will be available on request after the conference call. Please contact Claudia Nyffenegger or Gaby Strausak at +41 61 688 20 03.